RxDoctor Payments Data

Thanh-Tam Huynh

Physician Assistant · Newport Beach, CANPI 1164998803

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 440 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,148in general payments, 2019–2025

Across 440 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • Antares Pharma, Inc.$893
  • Recordati_rare_diseases_inc.$655
  • AbbVie$601
  • Novo Nordisk$542
  • Amgen$540
  • plus $4K from 38 others

What the payments were for

  • Food & beverage$8,116100%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,148 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide184$223,154
OzempicSemaglutide97$101,491
JardianceEmpagliflozin63$86,965
TrulicityDulaglutide12$19,952
FarxigaDapagliflozin Propanediol12$16,465
XyostedTestosterone Enanthate22$14,934
SynthroidLevothyroxine Sodium152$13,288
Tresiba Flextouch U-100Insulin Degludec15$10,390
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$7,102
Nano 2nd Gen Pen NeedlePen Needle, Diabetic55$3,857
TirosintLevothyroxine Sodium16$3,236
Humalog Kwikpen U-100Insulin Lispro15$2,657
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$2,528
Armour ThyroidThyroid,pork28$2,149
Levothyroxine Sodium141$1,748

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,059$243,106196 claims
Novo NordiskOzempic$542$101,49197 claims
Boehringer IngelheimJardiance$180$86,96563 claims
AstraZenecaFarxiga$33$16,46512 claims
AbbVieSynthroid, Armour Thyroid$601$15,438180 claims
Antares Pharma, Inc.Xyosted$893$14,93422 claims
IBSA Pharma Inc.Tirosint$14$3,23616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Newport Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →